'gio' sounds from the likes of your posts that you favor XXII becoming involved in this new and budding industry that has found a legal niche in the far western states. So you think that the company would see great returns in genetic engineering of the cannabis plant? You convey a solid front in why it should be part of the corporate strategy in advancing XXII's future in plant modification. Guess we will just have to see where 'ciggy' takes us.
News 
Market Data 
Discover 
